Cargando…

PAI-1 -675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study

A meta-analysis was performed to assess the association between the PAI-1 -675 4G/5G polymorphism and susceptibility to diabetes mellitus (DM), diabetic nephropathy (DN), diabetic retinopathy (DR) and diabetic coronary artery disease (CAD). A literature-based search was conducted to identify all rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Kuanfeng, Liu, Xiaoyun, Yang, Fan, Cui, Dai, Shi, Yun, Shen, Chong, Tang, Wei, Yang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818463/ https://www.ncbi.nlm.nih.gov/pubmed/24223897 http://dx.doi.org/10.1371/journal.pone.0079150

Ejemplares similares

Association Between - 675 ID, 4G/5G PAI-1 Gene Polymorphism and Pregnancy Loss: A Systematic Review
por: Adler, Grazyna, et al.
Publicado: (2018)

Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
por: Wang, Yongjie, et al.
Publicado: (2014)

Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study
por: Yousuf, Syed Douhath, et al.
Publicado: (2022)

PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis
por: Wang, Shangqian, et al.
Publicado: (2013)

No Association of SERPINE1 −675 Polymorphism With Sepsis Susceptibility: A Meta-Analysis
por: Shi, Chengfang, et al.
Publicado: (2015)

Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco
por: Hassani Idrissi, Hind, et al.
Publicado: (2016)

Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms
por: Sun, Wei, et al.
Publicado: (2013)

Association between Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Sepsis: A Meta-Analysis
por: Li, Li, et al.
Publicado: (2013)

Association of Plasminogen Activator Inhibitor-Type 1 (-675 4G/5G) Polymorphism with Pre-Eclampsia: Systematic Review
por: Morgan, Jessie A., et al.
Publicado: (2013)

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis
por: XU, XIN, et al.
Publicado: (2012)

Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population
por: Valdés-Alvarado, Emmanuel, et al.
Publicado: (2019)

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
por: Lorente, Leonardo, et al.
Publicado: (2015)

The −675 4G/5G Polymorphism in Plasminogen Activator Inhibitor-1 Gene Is Associated with Risk of Asthma: A Meta-Analysis
por: Nie, Wei, et al.
Publicado: (2012)

UCP2 -866G/A, Ala55Val and UCP3 -55C/T Polymorphisms in Association with Obesity Susceptibility — A Meta-Analysis Study
por: Qian, Li, et al.
Publicado: (2013)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
por: Živković, Maja, et al.
Publicado: (2014)

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
por: Wang, Ziran, et al.
Publicado: (2022)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

SUN-675 Breast Cancer Treatment Causes Diabetes
por: Silparshetty, Santh V S, et al.
Publicado: (2020)

In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time
por: de Lange, Zelda, et al.
Publicado: (2013)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
Publicado: (2021)

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction
por: Parpugga, Tajinder Kumar, et al.
Publicado: (2015)

Association of Adiponectin 45T/G Polymorphism with Diabetic Cardiovascular Complications in Korean Type 2 Diabetes
por: Ji, Myeong Jin, et al.
Publicado: (2018)

Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism
por: Mairuhu, ATA, et al.
Publicado: (2005)

The -844 G>A PAI-1 Polymorphism Is Associated with Acute Coronary Syndrome in Mexican Population
por: García-González, Ilian Janet, et al.
Publicado: (2015)

The +299(G>A) Resistin Gene Polymorphism and Susceptibility to Type 2 Diabetes in Thais
por: Suriyaprom, Kanjana, et al.
Publicado: (2009)

Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy
por: Saleem, Saba, et al.
Publicado: (2015)

Exploring a possible association between the occurrence of the SERPINE1-675 4G/5G (rs1799889) polymorphism and the increased risk of esophageal cancer in the Caucasian population
por: Klimczak-Bitner, Anna Agnieszka, et al.
Publicado: (2021)

The Role of Pai-1 Gene 4g/5g Polymorphism and Diagnostic Value of Biomarkers in Allergic and Non-Allergic Asthma Phenotype
por: Lampalo, Marina, et al.
Publicado: (2018)

Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms
por: Zhang, Xueya, et al.
Publicado: (2020)

Association of common polymorphisms in the IL2RA gene with type 1 diabetes: evidence of 32,646 individuals from 10 independent studies
por: Tang, Wei, et al.
Publicado: (2015)

Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina
por: Kumar, Sunil, et al.
Publicado: (2021)

Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children
por: De la Cruz-Mosso, Ulises, et al.
Publicado: (2012)

Circulating Levels of PAI-1 and SERPINE1 4G/4G Polymorphism Are Predictive of Poor Prognosis in HCC Patients Undergoing TACE()
por: Divella, Rosa, et al.
Publicado: (2015)

Pauli Manuscript Collection: A. Pais and G. E. Uhlenbeck
por: Pauli, Wolfgang
Publicado: (2002)

Correlation Between PPARGC1A Gene Rs8192678 G>A Polymorphism and Susceptibility To Type-2 Diabetes
por: Du, Fei, et al.
Publicado: (2019)

Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women
por: Mary, Maniraja Jesintha, et al.
Publicado: (2017)

Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients
por: Wang, Baoyan, et al.
Publicado: (2021)

The Effect of SOCS2 Polymorphisms on Type 2 Diabetes Mellitus Susceptibility and Diabetic Complications in the Chinese Han Population
por: Pan, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldhra9amv0228en15m2htn0j3k